Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,279.00    -32.40 (-2.47%)
Bid:
1,280.40
Ask:
1,280.80
Spread: 0.40 (0.031%)
Market Cap: £219.33b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Pre Stabilisation Notice

25 Oct 2024 11:02

RNS Number : 6985J
HSBC Holdings PLC
25 October 2024
 

25th October 2024

 

Swedbank AB

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Swedbank AB

Guarantor (if any):

na

Aggregate nominal amount:

EUR Benchmark

Description:

Fixed rate due 30 April 2029 4.5-year Green Senior Non-Preferred

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Continental Europe, CIC, LBBW, Natixis, Swedbank, UBS

Stabilisation period expected to start on:

25th October 2024

Stabilisation period expected to end no later than:

25th November 2024

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAUVVKRSKURURA
Date   Source Headline
11th Mar 202611:01 amRNSDirector/PDMR Shareholding
11th Mar 202611:01 amRNSDirector/PDMR Shareholding
11th Mar 202611:00 amRNSOverseas Regulatory Announcement - Grant of Awards
11th Mar 202611:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th Mar 20264:00 pmRNSIssuance of senior unsecured notes
10th Mar 20264:00 pmRNSIssuance of senior unsecured notes
10th Mar 20268:31 amRNSHolding(s) in Company
10th Mar 20268:31 amRNSHolding(s) in Company
5th Mar 20262:46 pmRNSHolding(s) in Company
5th Mar 20262:44 pmRNSHolding(s) in Company
4th Mar 20264:30 pmRNSDirector/PDMR Shareholding
4th Mar 20264:07 pmRNSHolding(s) in Company
3rd Mar 20265:25 pmRNSHolding(s) in Company
2nd Mar 202610:00 amRNSDirector Declaration / Subsidiary Board Role
27th Feb 20264:30 pmRNSDocuments Available at NSM
27th Feb 20263:30 pmRNSDirector/PDMR Shareholding
27th Feb 20263:20 pmRNSHolding(s) in Company
27th Feb 20263:00 pmRNSTotal Voting Rights
27th Feb 20261:10 pmRNSPublication of base prospectus supplement
25th Feb 20264:30 pmRNSDocuments Available at NSM
25th Feb 20263:29 pmRNSHolding(s) in Company
25th Feb 20269:28 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSAnnual results 2025 Zoom meeting
25th Feb 20267:00 amRNSHSBC Holdings 2025 Results
12th Feb 20267:00 amRNSHolding(s) in Company
11th Feb 20264:00 pmRNSNotice of redemption
10th Feb 20264:12 pmRNSHolding(s) in Company
10th Feb 20268:30 amRNSOverseas Regulatory Announcement - Board Meeting
9th Feb 20265:34 pmRNSHolding(s) in Company
4th Feb 20264:40 pmRNSHolding(s) in Company
2nd Feb 20264:05 pmRNSHolding(s) in Company
2nd Feb 20269:52 amRNSHolding(s) in Company
30th Jan 20263:30 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSHolding(s) in Company
28th Jan 20264:15 pmRNSHolding(s) in Company
26th Jan 20268:30 amRNSPrivatisation of Hang Seng Bank- Scheme Effective
23rd Jan 20268:30 amRNSPrivatisation of Hang Seng Bank- Court Sanction
23rd Jan 20267:00 amRNSHolding(s) in Company
19th Jan 20263:09 pmRNSHolding(s) in Company
15th Jan 20265:38 pmRNSTR1 Notification of major interest in shares
13th Jan 202610:00 amRNSOverseas Regulatory Announcement - Grant of Awards
8th Jan 202610:55 amRNSPrivatisation of HangSengBank- Results of Meetings
5th Jan 20263:00 pmRNSBlock listing Interim Review
30th Dec 20259:00 amRNSPost Stabilisation Notice
30th Dec 20259:00 amRNSPost Stabilisation Notice
29th Dec 20253:00 pmRNSTotal Voting Rights
29th Dec 20253:00 pmRNSTotal Voting Rights
23rd Dec 20257:00 amRNSBoard Changes
22nd Dec 20253:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.